Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: A double-blind, placebo-controlled study

Double Blind ◽

Double Blind Placebo ◽

Evaluation of the dose—response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2009.12.006 ◽

2009 ◽

Vol 31 (12) ◽

pp. 2839-2850 ◽

Cited By ~ 12

Author(s):

Juan G. Puig ◽

Heribert Schunkert ◽

Addison A. Taylor ◽

Sam Boye ◽

James Jin ◽

...

Keyword(s):

Essential Hypertension ◽

Dose Response ◽

Controlled Study ◽

Response Relationship ◽

Double Blind ◽

Direct Renin Inhibitor ◽

Parallel Group ◽

Stage 1 ◽

Analgesic and anti-inflammatory dose–response relationship of 7.5 and 15mg meloxicam after lower third molar removal: a double-blind, randomized, crossover study

International Journal of Oral and Maxillofacial Surgery ◽

10.1016/j.ijom.2006.09.006 ◽

2007 ◽

Vol 36 (1) ◽

pp. 26-31 ◽

Cited By ~ 24

Author(s):

A.M. Calvo ◽

V.T. Sakai ◽

F.P.M. Giglio ◽

K.C.S. Modena ◽

B.L. Colombini ◽

...

Keyword(s):

Crossover Study ◽

Dose Response ◽

Third Molar ◽

Response Relationship ◽

Double Blind ◽

Anti Inflammatory ◽

Relationship Of ◽

Randomized Crossover Study

Smoking and Parkinson's disease: A dose-response relationship

Neurology ◽

10.1212/wnl.52.1.115 ◽

1999 ◽

Vol 52 (1) ◽

pp. 115-115 ◽

Cited By ~ 151

Author(s):

J. M. Gorell ◽

B. A. Rybicki ◽

C. C. Johnson ◽

E. L. Peterson

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dose Response ◽

Response Relationship ◽

Dose Response Relationship

P2.098 Saflnamide as an adjunct to levodopa signiflcantly improved motor fluctuations in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70449-3 ◽

2009 ◽

Vol 15 ◽

pp. S115

Author(s):

R. Borgohain ◽

J. Szasz ◽

M. Bhatt ◽

S. Rossetti ◽

V. Lucini ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Fluctuations ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease

Movement Disorders ◽

10.1002/mds.870130505 ◽

1998 ◽

Vol 13 (5) ◽

pp. 782-787 ◽

Cited By ~ 37

Author(s):

Richard B. Dewey ◽

Demetrius M. Maraganore ◽

J. Eric Ahlskog ◽

Joseph Y. Matsumoto

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Rescue Agent

Dose Response Relationship of Child Centered Task Oriented Training in Children with Cerebral Palsy-A Randomized Controlled Study. Study Protocol

Indian Journal of Public Health Research & Development ◽

10.5958/0976-5506.2019.01838.2 ◽

2019 ◽

Vol 10 (7) ◽

pp. 17

Author(s):

Kovela Rakesh Krishna ◽

K U Dhanesh Kumar

Keyword(s):

Cerebral Palsy ◽

Dose Response ◽

Controlled Study ◽

Response Relationship ◽

Randomized Controlled ◽

Children With Cerebral Palsy ◽

Child Centered ◽

Task Oriented ◽

P2.108 Improvements in symptom severity and daily living with saflnamide in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70459-6 ◽

2009 ◽

Vol 15 ◽

pp. S118

Author(s):

J. Szasz ◽

R. Borgohain ◽

M. Bhatt ◽

S. Rossetti ◽

V. Lucini ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Symptom Severity ◽

Daily Living ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension

American Heart Journal ◽

10.1016/0002-8703(93)90762-x ◽

1993 ◽

Vol 125 (6) ◽

pp. 1704-1710 ◽

Cited By ~ 11

Author(s):

Jawahar L. Mehta ◽

Larry M. Lopez ◽

Nicholas D. Vlachakis ◽

Alan H. Gradman ◽

David T. Nash ◽

...

Keyword(s):

Essential Hypertension ◽

Dose Response ◽

Response Relationship ◽

Double Blind ◽

Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease

Neurology ◽

10.1212/wnl.20.12_part_2.6 ◽

1970 ◽

Vol 20 (Issue 12, Part 2) ◽

pp. 6-12 ◽

Cited By ~ 15

Author(s):

M. D. Muenter

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Levodopa Therapy ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Pharmacodynamics and Dose-Response Relationship of Famotidine: A Double-Blind Randomized Placebo-Controlled Trial

The Journal of Clinical Pharmacology ◽

10.1002/j.1552-4604.1993.tb04716.x ◽

1993 ◽

Vol 33 (7) ◽

pp. 636-639 ◽

Cited By ~ 5

Author(s):

Oscar L. Laskin ◽

Patricia M. Patterson ◽

Sumiko Shingo ◽

Kenneth C. Lasseter ◽

E. Cooper Shamblen

Keyword(s):

Dose Response ◽

Controlled Trial ◽

Response Relationship ◽

Double Blind ◽